To help pharmaceutical companies answer this question, Kaiser Associates conducted a comprehensive analysis of nearly every pharma R&D program in the world and compiled the findings into the Hot Indications List.
Their report includes:
Kaiser’s ranking and analysis of the Top 50 indications
4 Therapeutic Area Deep Dives
Top 10 Emerging Orphan Diseases
You can download the report at this address:
Source: Kaiser Associates